| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.040 | 19.897 | 13.998 | 12.474 | 18.109 | 12.612 | 13.698 |
| Total Income - EUR | - | - | - | 3.043 | 19.900 | 14.004 | 12.601 | 18.111 | 12.615 | 13.700 |
| Total Expenses - EUR | - | - | - | 3.830 | 19.817 | 13.488 | 11.760 | 15.249 | 11.137 | 11.011 |
| Gross Profit/Loss - EUR | - | - | - | -787 | 84 | 516 | 841 | 2.861 | 1.478 | 2.688 |
| Net Profit/Loss - EUR | - | - | - | -817 | -115 | 376 | 715 | 2.680 | 1.275 | 2.207 |
| Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Apliherb S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 4.479 | 4.059 | 4.557 | 2.756 | 4.180 | 4.941 | 5.124 |
| Inventories | - | - | - | 3.775 | 2.713 | 2.719 | 2.345 | 2.047 | 3.181 | 998 |
| Receivables | - | - | - | 302 | 0 | 0 | 29 | 0 | 16 | 118 |
| Cash | - | - | - | 402 | 1.346 | 1.838 | 382 | 2.133 | 1.745 | 4.008 |
| Shareholders Funds | - | - | - | -774 | -875 | -483 | 243 | 2.924 | 4.190 | 4.625 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 5.254 | 4.934 | 5.040 | 2.512 | 1.256 | 751 | 499 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Apliherb S.r.l.